โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT07145229RECRUITINGIRB Ready

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Sponsored by Atom Therapeutics Co., Ltd

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...
๐Ÿ“Š
1 of 380 participants interested
0% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy of ABP-745 in reducing pain and swelling compared with standard colchicine treatment and placebo will be evaluated in participants with acute gout. The primary efficacy measurement will be pain score after treatment.

Who Can Participate

Inclusion Criteria

Subjects are eligible for the study if they meet all of the following Inclusion Criteria:
Age 18-70 years old (inclusive), male or female.
Body mass index (BMI)18-40 kg/m2 (inclusive).
Medical history and current findings consistent with diagnosis of gouty arthritis.
Subjects must have experienced 2 or more gout flares within 12 months prior to screening.
Onset of an acute gout flare, within 6 months
Patients receiving ULT agents (such as allopurinol, febuxostat, probenecid, etc.) must be on stable doses of these drugs prior to first dose of study drug (and remain on the same dose throughout the Treatment Period).
Subjects agree to maintain a stable lifestyle (such as diet and exercise) during the study period. Key

Exclusion Criteria

Subjects are excluded from the study if one or more of the following criteria are met:
Administration of oral prednisone โ‰ฅ 10 mg or equivalent doses of other glucocorticoids, or use of narcotics, within 24 hour

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

380 participants

๐ŸŽ‚

Age Range

18 Years - 70 Years

โšง

Gender

ALL

๐Ÿข

Sponsor

Atom Therapeutics Co., Ltd

Study Locations

Choose your preferred location or select flexible during enrollment

RECRUITING

Peoria

Arizona

Location available
View Peoria location page
RECRUITING

La Mesa

California

Location available
View La Mesa location page
NOT_YET_RECRUITING

Norcross

Georgia

Location available
View Norcross location page
RECRUITING

Naperville

Illinois

Location available
View Naperville location page
RECRUITING

Des Moines

Iowa

Location available
View Des Moines location page
RECRUITING

Alexandria

Louisiana

Location available
View Alexandria location page
RECRUITING

Baton Rouge

Louisiana

Location available
View Baton Rouge location page
RECRUITING

New Orleans

Louisiana

Location available
View New Orleans location page
RECRUITING

Lutherville

Maryland

Location available
View Lutherville location page

๐Ÿ“ And 5 more locations available

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Looking for Gout Treatment in Alexandria?

Join others in Louisiana exploring innovative treatment options through clinical research

Gout Treatment Options in Alexandria, Louisiana

If you're searching for Gout treatment in Alexandria, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Alexandria, New Orleans, Prairieville and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Gout. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Louisiana
Now Enrolling
Up to 380 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Gout?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Gout

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Gout Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT07145229. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.